High-dose cyclophosphamide (NSC-26271) for recurrent or progressive ovarian adenocarcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D012008:Recurrence; D018805:Sepsis / Q000209:etiology; D012882:Skin Tests
D003520:Cyclophosphamide